Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis
Review
Overview
Research
Additional Document Info
View All
Overview
publication date
June 1, 2022
webpage
Web of Science
published in
IMMUNOTHERAPY
Journal
Research
keywords
biologics
chronic rhinosinusitis
dupilumab
mepolizumab
nasal polyposis
omalizumab
Additional Document Info
start page
655
end page
662
volume
14
issue
8